Derive insights from population-level genomics
Better understand the dynamics of pathways and intricate biomarkers such as androgen receptor activity, DNA repair, immune profiling or chemotherapy response activation.
Reveal new biomarkers through comprehensive genomic profiling
We can profile your cohorts using the whole-transcriptome platform in our CLIA-certified, CAP-accredited, NYS-approved laboratory. With this service, you also gain access to the full repertoire of signatures from the GRID.
Enable clinical trials in earlier patient populations
Utilize more than 500 genomic signatures and 70,000 profiles in the GRID database to identify new niche populations for clinical trial design.
Commercialize your therapies faster
Screen and identify patients efficiently for clinical trial enrollment through our prospective profiling of hundreds of patients per week.
Partner With Us
Business and partnership inquiries:
Corporate Headquarters and CAP/CLIA Laboratory:
10355 Science Center Drive
Suite 240, San Diego
Research and Development:
1152 Mainland Street
Suite 430, Vancouver
BC V6B 4X2